The impact of meningitis vaccines and their future role

May 6, 2016

Source: Prescriber, 2016, 27 (3), pp. 37-41

Follow this link for abstract

Date of publication: March 2016

Publication Type: Analysis

In a nutshell: The success of the meningococcal group A (MenA) vaccination in the African meningitis belt, public support for the extension of the MenB vaccination in the UK and the importance of vaccination in the fight against antimicrobial resistance all endorse the need for additional meningitis vaccines in the future.

Length of publication: 5 page article


Enter B and W: two new meningococcal vaccine programmes launched

December 21, 2015

Source: Archives of Diseases in Childhood, 2016, 101 (1), pp. 91-95

Follow this link for abstract

Date of publication: October 2015

Publication Type: Review

In a nutshell: In 2015, the UK became the first country in the world to have a comprehensive routine meningococcal vaccine programme targeting all of the main capsular groups of N. meningitidis. 1 An infant vaccine programme against meningococcal capsular group B Neisseria meningitidis (MenB) was launched from 1st September with an aim to reduce endemic MenB disease in early childhood. On 1st August 2015, an adolescent programme against groups A, C, W and Y meningococci (MenACWY) was rolled out to halt a growing outbreak of capsular group W disease (MenW) caused by a hypervirulent clone of N. meningitidis, in addition to maintaining control against MenC disease provided by the current adolescent programme.

Length of publication: 5 page article

Meningitis vaccine should be followed up with paracetamol

October 12, 2015

Source: Nursing Times

Follow this link for abstract

Date of publication: September 2015

Publication Type: News

In a nutshell: Nurses delivering a new vaccine protecting against meningitis should encourage parents to give their children paracetamol following immunisation, due to increased risk of fever. It marks a change from previous advice warning against paracetamol use after immunisation due to study evidence that it could reduce the efficacy of vaccinations.

Length of publication: 1-page

Saving lives from meningitis in 2015

September 7, 2015

Source: Practice Nursing, 2015, 6 (9), pp. 422 

Follow this link for abstract

Date of publication: September 2015

Publication Type: Editorial

In a nutshell: This has been a landmark year in combatting meningococcal meningitis and septicaemia, with MenACWY vaccination for adolescents beginning over the summer, and the long-awaited introduction of MenB vaccine for babies from September. Meningococcal disease remains the most important cause of bacterial meningitis and septicaemia in healthy UK babies, toddlers and young adults.

Length of publication: 1-page

Recent changes to the routine childhood immunization schedule

September 1, 2015

Source: Practice Nursing, 2015, 26 (8), pp. 386 – 392

Follow this link for abstract

Date of publication: August 2015

Publication Type: Journal Article

In a nutshell: Practice nurses play a key role in both promoting the uptake of immunizations and administering them, ensuring that every child benefits from this important public health intervention. Karen Ford discusses recent changes to the childhood immunization schedule

Length of publication: 6-page article

Meningitis B vaccine offered to all babies from September

June 25, 2015

Source: BBC News

Follow this link for full-text

Date of publication: June 2015

Publication Type: News

In a nutshell: All newborn babies in England and Scotland are to be offered a vaccine to combat meningitis B from September, the government has announced. The Men B vaccine will be given to babies at two months, four months and 12 months old. The scheme, which has been delayed by cost disputes, is the first national and publicly-funded programme against the deadly infection in the world.

Length of publication: 1-page article

Teenagers in England to be vaccinated against meningitis group W

April 28, 2015

Source: The BMJ, 2015; 350

Follow this link for abstract

Date of publication: March 2015

Publication Type: News

In a nutshell: Teenagers in England are to be vaccinated against meningitis W after a worrying rise in the incidence of meningococcal group W disease since 2009. The Joint Committee on Vaccination and Immunisation has recommended that a vaccination programme for 14-18 year olds should be implemented as soon as possible, to generate herd protection against meningitis W for the rest of the population. The independent advisory committee said, “Levels of disease were consistent with an outbreak situation, with cases and deaths occurring in all age ranges, constituting a public health emergency.” The Department of Health for England has accepted the advice and is now planning a vaccination programme that will use an already licensed quadrivalent conjugate vaccine that protects against four meningitis serotypes: A, C, W, and Y. This would replace the group C vaccine already offered to teenagers.

Length of publication: 1-page news story